Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
05/2005
05/03/2005CA2157234C Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives
04/2005
04/28/2005WO2005037819A1 Process for the preparation of (s)-glyceraldehyde acetonide
04/28/2005WO2005037818A1 Novel fluorine-containing dioxolane compound and novel fluorine-containing polymer
04/28/2005WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
04/28/2005WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005US20050090543 Method for the preparation of tetrahydrobenzothiepines
04/28/2005CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005CA2541491A1 Process for the preparation of (s)-glyceraldehyde acetonide
04/28/2005CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
04/28/2005CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use
04/27/2005EP1525235A1 Microstructure chain transfer agents for anionic polymerization
04/27/2005EP1525192A2 Co-surfactants based on aldehydes
04/27/2005EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
04/27/2005EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085638 Process for producing dioxolane nucleoside analogues
04/21/2005US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
04/21/2005US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
04/21/2005US20050085426 Acid-sensitive compounds, preparation and use thereof
04/21/2005US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/20/2005EP1156042B1 Process for the preparation of glycerol carbonate
04/20/2005CN1197858C Process for producing cyclic formal
04/20/2005CN1197837C Method for preparing polyenoid dialdehyde monoaldehyde acetal
04/19/2005CA2333199C Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
04/14/2005WO2005000777A3 Process for the preparation of cinnamaldehyde compounds
04/14/2005WO2004013120A8 Novel benzodioxoles
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
04/13/2005CN1606552A Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
04/13/2005CN1196694C Polymerisable, optically active dioxolane diesters
04/13/2005CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
04/13/2005CN1196666C Process for preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
04/13/2005CN1196464C Novel coloring agent for use in oxidative hair dyeing
04/07/2005WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005WO2004069777A8 Method for producing alkylene derivative and method for regenerating catalyst for producing alkylene derivative
04/07/2005CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/06/2005EP0960096B1 Substituted beta-thiocarboxylic acids
04/06/2005CN1195514C Metabolites of ecteinascidin 743
04/05/2005US6875884 Urea derivatives as inhibitors for CCR-3 receptor
04/05/2005US6875760 Glucagon antagonists/inverse agonists
03/2005
03/31/2005WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor
03/31/2005WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/31/2005US20050070724 Process for the preparation of cyclic carbonates
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1517885A2 Aminoacetonitrile derivatives suitable for controlling parasites
03/30/2005EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators
03/30/2005EP1444197B1 Novel phenyl-propargylether derivatives
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872741 Sodium channel modulators
03/24/2005WO2005027157A2 Salt fusible at ordinary temperature and electrochemical device
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026134A1 Organic compounds
03/24/2005WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005CA2539016A1 Organic compounds
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1419125A4 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
03/23/2005CN1599716A Aminoacetonitrile derivatives and their use for controlling parasites
03/23/2005CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/16/2005EP1318824B1 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005CN1594311A Novel spiro compound bulbophyllispiradienone having activities of anti-cancer and inhibiting NO release and its derivatives
03/16/2005CN1594310A Method for extracting sesamin from sesame oil root
03/16/2005CN1594309A Diphenoxybenzyl compounds having activities of anti-cancer and inhibiting macrophage from releasing NO
03/16/2005CN1593230A Alkyldienamides exhibiting taste and sensory effect in flavor compositions
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/15/2005US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/15/2005US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives
03/15/2005US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs
03/15/2005US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity
03/10/2005WO2005021526A2 Method for producing fluorinated 1,3-dioxolane compounds, fluorinated 1,3-dioxolane compounds, fluorinated polymers of the fluorinated 1,3-dioxolane compounds, and optical or electrical materials using the polymers
03/10/2005WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005WO2005020911A2 Benzo[1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005US20050054879 acetalization of aromatic aldehydes with alcohols, then hydrogenation of the acetalsin the presence of acid catalysts and hydrolysis to form pure aldehydes used as raw material for perfumes or chemical intermediates for drugs; efficiency
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050053861 Onium salt compound and radiation-sensitive resin composition
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 183